|
GeneEd expands its product offering to span
all subject areas, from molecular medicine to patient education.
San Francisco, CA, March 17, 2003—
GeneEd, Inc., the leading provider of advanced e-Learning solutions
for the life science industry, today announced that it has extended
its e-Learning curriculum from drug discovery to patient education.
The GeneEd patient education curriculum announced today (in addition
to the over 100 therapeutic area courses released over the last
two quarters) represents a significant expansion of GeneEd’s
product line. GeneEd products are extensively used in the research,
development and sales divisions of major global pharmaceutical organizations.
In combination with the soon-to-be-released regulatory and compliance
curriculum, the patient education program greatly enhances the GeneEd
product portfolio to address all of the mission-critical training
needs of modern life science organizations.
As the role of “molecular medicine” broadens its reach
within pharmaceutical organizations, employees, physicians and patients
alike are required to absorb the complex scientific and medical
issues this new science brings. GeneEd is the only organization
providing validated e-Learning across the spectrum. These techniques
range from genomics and proteomics, through disease states, all
the way to physician and patient education. GeneEd is utilizing
its award-winning, proprietary Repurposing™ and Viewing™
engine technology to offer compelling, intuitive and effective e-Learning
to some of the most demanding users of information – everyday
patients trying to better understand their diseases and the therapeutics
that may help them.
"The commencement of the Patient Education curriculum places
GeneEd at the nexus of deployment of e-Learning to patients."
said Salil Patel, Chief Scientific Officer for GeneEd. "These
new patient education e-Learning courses empower physicians, allied
health professionals, and patients alike with the knowledge critical
to the understanding of their diseases, and the therapeutic regimens
used to treat them. GeneEd is actively responding to the ever-changing
training needs of the life science industry, and the introduction
of this new patient education curriculum reiterates the strength
of our science-focused curriculum design."
All GeneEd catalog and custom courseware are Continuing Medical
Education (CME) Category One accredited and approved. The GeneEd
Patient Education E-Learning curriculum has also been developed
to allow simple technical integration of the courses into a pharmaceutical
organization's Learning Management System (LMS). All GeneEd E-Learning
courses are SCORM 1.2 compliant, and have been successfully integrated
with 21 CFR Part 11-compliant LMS applications.
About GeneEd
GeneEd, Inc. was founded in 1997 to provide life science and healthcare
e-learning solutions for the pharmaceutical, biotechnology, instrument
and medical device, and hospital/HMO industries. GeneEd's Life Science
industry customers include AstraZeneca, Pfizer, Genentech, the ALZA
division of Johnson & Johnson, Celera, Bio-Rad, and IBM Life
Sciences, amongst many others. (http://www.geneed.com/customers.html)
GeneEd utilizes the best life science content, combined with advanced
e-learning development technology, to rapidly create basic and advanced
curricula in the areas of genomics, therapeutic area training (for
clinical research, product development, and sales and marketing
teams), computer assisted drug design, drug discovery and development,
pharmacogenomics and clinical genomics, bioinformatics and microarray
informatics, and therapeutic and diagnostic products. GeneEd, Inc.
is a privately held company headquartered in San Francisco, California.
Visit http://www.GeneEd.com
for additional information about GeneEd and its courseware.
|
